Blood clotting in minimally altered whole blood

Blood

Volumn 88, Issue 9, 1996, Pages 3432-3445

  Rand, Matthew D ^a   Lock, Jennifer B ^a   Van't Veer, Cornelis ^a   Gaffney, Donald P ^a   Mann, Kenneth G ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; FIBRINOGEN; FIBRINOPEPTIDE A; PROTHROMBIN; THROMBIN; THROMBOCYTE FACTOR 4;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PARTIAL THROMBOPLASTIN TIME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOPLASTIN TIME;

EID: 0029858330     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3432.bloodjournal8893432     Document Type: Article

References (80)

1. Mann KG, Gaffney D, Bovill EG: Molecular biology, biochemistry and life-span of plasma coagulation factors, in Beutler E, Lichtman MA, Coller BS, Kipps TJ, (eds): Williams Hematology (ed 5). New York, NY, McGraw-Hill, Inc, 1995, p 1206
2. Bauer KA, Rosenberg RD: Control of coagulation reactions, in Beutler E, Lichtman MA, Coller BS, Kipps TJ, (eds): Williams Hematology (ed 5). New York, NY, McGraw-Hill, Inc, 1995, p 1239
3. Broze GJ Jr: The tissue factor pathway of coagulation: factor VII, tissue factor, and tissue factor pathway inhibitor, in Bloom AL, Forbes CD, Thomas DP, Tuddenham, EGD (eds): Haemostasis and Thrombosis, vol 1, (ed 3). New York, NY, Churchill Livingstone, 1994, p 349
4. Tollefsen DM, Majerus DW, Blank MK: Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem 257:2162, 1982
5. Fuchs HE, Pizzo SV: Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. J Clin Invest 72:2041, 1983
6. Tracy PB, Peterson JM, Nesheim ME, McDuffie FC, Mann KG: Interaction of coagulation factor V and factor Va with platelets. J Biol Chem 254:10354, 1979
7. Miletich JP, Jackson CM, Majerus PW: Properties of the factor Xa binding site on human platelets. J Biol Chem 434, 1978
8. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 263:4743, 1989
9. Tracy PB, Eide LL, Mann KG: Human prothrombinase complex assembly and function on isolated peripheral blood populations. J Biol Chem 260:2119, 1985
10. Colman R, Marder VJ, Salzman EW, Hirsh J: Plasma coagulation factors, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Philadelphia, JB Lippincott, 1994, p 3
11. Gailani D, Broze GJ Jr: Factor XI activation in a revised model of blood coagulation. Science 253:909, 1991
12. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
13. Lawson JH, Butenas S, Mann KG: The evaluation of complex-dependent alterations in human factor Vila. J Biol Chem 267:4834, 1992
14. Osterud B, Rapaport S: Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74:5260, 1977
15. Jesty J, Silverberg SA: Kinetics of the tissue factor-dependent activation of coagulation factors IX and X in a bovine plasma system. J Biol Chem 254:12337, 1979
16. Foster WB, Nesheim ME, Mann KG: The factor Xa-catalyzed activation of factor V. J Biol Chem 258:13970, 1983
17. Rick ME: Activation of factor VIII by factor IXa. Blood 60:744, 1982
18. Butenas S, Mann KG: Kinetics of human factor VII activation. Biochemistry 35:1904, 1996
19. Warr TA, Rao LVM, Rapaport SI: Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 75:1481, 1990
20. Thackrah CT: An inquiry into the nature and properties of the blood. London, UK, Cox, 1819
21. Lawson JH, Mann KG: Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 266:11317, 1991
22. Broze GJ Jr, Warren LA, Novotny WF, Higuchi Da, Girard JJ, Miletich JP: The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71:335, 1988
23. Nesheim ME, Taswell JB, Mann KG: The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 254:10952, 1979
24. Mann KG, Jenny RJ, Krishnaswamy S: Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915, 1988
25. Naito K, Fujikawa K: Activation of human blood coagulation factor XI independent of factor XII, Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266:7535, 1988
26. Hung DT, Vu T-KH, Wheaton VI, Ishii K, Coughlin SR: Cloned platelet IIa receptor is necessary for IIa-induced platelet activation. J Clin Invest 89:1350, 1992
27. Shafer JA, Higgins DL: Human Fibrinogen. CRC Clinical Reviews in Clinical Laboratory Sciences 26:1, 1988
28. Hermans J, McDonagh J: Fibrin: Structure and interactions. Semin Thromb Hemostas 8:11, 1982
29. Doolittle RF: Fibrinogen and fibrin. Sci Am 1245:126, 1981
30. Nemerson Y: Tissue factor and hemostasis. Blood 71:1, 1988
31. Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffman T: Evidence for the presence of tissue factor activity on subendothelium. Blood 73:968, 1989
32. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:2839, 1989
33. Forman SD, Nemerson Y: Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: Fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci USA 83:4675, 1986
34. Bouma BN, Griffin JH: Human blood coagulation Factor XI: Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 252:64327, 1977
35. Fujikawa K, Heimark RL, Kurachi K, Davie EW: Activation of bovine factor XII (Hageman factor) by plasma kallikrein. Biochemistry 19:1322, 1980
36. Hoak JC, Swanson LW, Warner ED, Connor WE: Myocardial infarction associated with severe factor XII deficiency. Lancet 2:884, 1966
37. Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP: Williams Trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 56:1650, 1975
38. Lawson JH, Kalafatis M, Stram S, Mann KG: A model for the tissue factor pathway to thrombin. J Biol Chem 269:23357, 1994
39. van't Veer C, Kalafatis M, Mann KG: Tissue factor pathway to thrombin V. Influence of protein C in combination with TFPI on prothrombin activation. Blood 86:1128a, 1995
40. van't Veer C, Mann KG: Tissue factor pathway to thrombin IV. Regulation by the stoichiometric inhibitors TFPI and AT-III. Blood 86:1777a, 1995
41. leiden. Blood 86:2444a, 1995 (abstr, suppl 1)
42. Nelsestuen GL: Role of y-carboxyglutamic acid. An unusual transition required for calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 251:5648, 1976
43. Kessels H, Beguin S, Andree H, Hemker HC: Measurement of thrombin generation on whole blood - The effect of heparin and aspirin. Thromb Haemost 72:78, 1994
44. Mann KG: Prothrombin. Methods Enzymol 45:123, 1976
45. Lundblad RL, Kingdon HS, Mann KG: Thrombin. Methods Enzymol 45:156, 1976
46. Nesheim M, Katzmann JA, Tracy PB, Mann KG: Factor V. Methods Enzymol 80:249, 1981
47. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG: Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 78:162, 1981
48. Barenholz Y, Gibbes D, Litman BJ, Goll J, Thompson TE, Carlson FD: A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 16:2806, 1977
49. Lawson JH, Krishnaswamy S, Butenas S, Mann KG: Extrinsic pathway proteolytic activity. Methods Enzymol 222:177, 1993
50. McDuffie FC, Peterson JM, Clark G, Mann KG: Antigenic changes produced by complex formation between thrombin and antithrombin III. J Immunol 127:239, 1981
51. Kalafatis M, Bertina RM, Rand MD, Mann KG: Characterization of the molecular defect in factor VR506Q. J Biol Chem 270:4053, 1995
52. Foster WB, Tucker MM, Katzmann JA, Miller RS, Mann KG: Monoclonal antibodies to human coagulation factor V and factor Va. Blood 61:1060, 1983
53. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
54. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
55. Mihalyi E: Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations. Biochemistry 27:976, 1988
56. Higgins DL, Lewis SD, Shafer JA: Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. J Biol Chem 258:9276, 1983
57. Amiral J, Walenge JM, Fareed J: Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A. Semin Thromb Hemost 10:228, 1984
58. Biggs R, Nossel HL: Tissue extract and the contact reaction in blood coagulation. Thrombosis et diathesis Haemorrhagica 6:1, 1961
59. Hojima Y, Pierce JV, Pisano JJ: Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res 20:149, 1980
60. Ruf W, Edgington TS: An anti-tissue factor monoclonal antibody which inhibits TF-VIIa complex is a potent anticoagulant in plasma. Thromb Haemost 66:529, 1991
61. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93:114, 1994
62. Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB: The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem 270:20794, 1995
63. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994
64. Tracy PB, Eide LL, Bowie EJW, Mann KG: Radioimmunoassay of factor V in human plasma and platelets. Blood 60:59, 1982
65. Olson ST, Bjork I, Shore JD: Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol 222:525, 1993
66. Chesterman CN, McGready JR, Doyle DJ, Morgan FJ: Plasma levels of platelet factor 4 measured by radioimmunoassay. Br J Haematol 40:489, 1978
67. Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ: Antiheparin proteins secreted by human platelets. Purification, characterization and radioimmunoassay. Blood 53:47, 1979
68. DiScipio RG, Hermodson MA, Yates SG, Davie EW: A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 16:698, 1977
69. Downing MR, Butkowski RJ, Clark MM, Mann KG: Human prothrombin activation. J Biol Chem 250:8897, 1975
70. Suzuki K, Nishioka J, Hayashi T, Kosaka Y: Functionally active thrombomodulin is present in human platelets. J Biochem 104:628, 1988
71. Kung C, Hayes E, Mann KG: A membrane-mediated catalytic event in prothrombin activation. J Biol Chem 269:25838, 1994
72. Rabiet MJ, Blashill A, Furie B, Furie BC: Prothrombin fragment 1.2.3, a major product of prothrombin activation in human plasma. J Biol Chem 261:13210, 1986
73. Teitel JM, Bauer KA, Lau HK, Rosenberg RD: Studies of prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex. Blood 59:1086, 1982
74. Olson ST, Shore JD: Demonstration of a two step reaction mechanism for inhibition of a-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891, 1982
75. Owen W: Evidence for the formation of an ester between thrombin and heparin cofactors. Biochim Biophys Acta 405:380, 1975
76. Myrmel KH, Lundblad RL, Mann KG: Characteristics of the association between prothrombin fragment 2 and α-thrombin. Biochemistry 15:1767, 1976
77. Walker FJ, Esmon CT: The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III. J Biol Chem 254:5618, 1979
78. Tans G, Janssen-Claessen T, Hemker HC, Zwaal RFA, Rosing J: Meizothrombin formation during factor Xa-catalyzed prothrombin activation. J Biol Chem 266:21864, 1991
79. Kumar R, Beguin S, Hemker HC: The influence of fibrinogen and fibrin on thrombin generation - Evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 72:713, 1994
80. Biedermann B, Rosenmund A, Muller M, Kohler HP, Haeberli A, Straub PW: Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro. J Lab Clin Med 124:339, 1994